0001387131-18-001156.txt : 20180320 0001387131-18-001156.hdr.sgml : 20180320 20180320200456 ACCESSION NUMBER: 0001387131-18-001156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180316 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannon Louis A CENTRAL INDEX KEY: 0001700257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 18703157 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD, SUITE 105 CITY: WALTHAM STATE: ME ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 4 1 cannon-form4_031618.xml OWNERSHIP DOCUMENT X0306 4 2018-03-16 0 0001528557 Corindus Vascular Robotics, Inc. CVRS 0001700257 Cannon Louis A 309 WAVERLEY OAKS ROAD, SUITE 105 WALTHAM MA 02452 1 0 0 0 Common Stock 7557436 I see footnotes Common Stock 62268 D Series A Preferred Stock 1.25 2018-03-16 4 A 0 40000 25 A 2018-03-16 Common Stock 800000 40000 I See footnote Warrant 1.4 2018-03-16 4 A 0 350000 0 A 2018-09-16 2028-03-16 Common Stock 350000 350000 I See footnote These securities were inadvertently omitted from Dr. Cannon's prior Section 16 reports. Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein. 50,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly. The preferred stock is perpetual and therefore has no expiration date. /s/ Louis A. Cannon 2018-03-20